RA
Live / Registered — Registered (as of 07 May 2024)
What this means for you
Registered since 07 May 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90263893
- Registration number
- 7381054
- Mark type
- Word mark
- Filed
- 19 Oct 2020
- Published for opposition
- 17 Aug 2021
- Registered
- 07 May 2024
- Attorney of record
- Jennifer Waitman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of wrinkles; Dermatological pharmaceutical products and pharmaceutical preparations injected into or under the skin, into or under mucous membranes for filling in wrinkles, skin depressions for remodeling, increasing volume in the face, for moisturizing the skin or mucous membranes, for increasing lip volume; none of the foregoing are for prevention or treatment of rheumatoid arthritis
Owner
- Revance Therapeutics, Inc., GLENGORMLEY, DE, US
- Revance Therapeutics, Inc., Newark, CA, US
- Revance Therapeutics, Inc., Newark, CA, US
Prosecution history
- 20 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 02 Apr 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Apr 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Feb 2024 — USE AMENDMENT FILED
- 05 Mar 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL